AstraZeneca Pharma India has appointed Praveen K. Mittal, a seasoned public policy and industry affairs professional with nearly three decades of experience, as Director – Corporate Affairs, marking a strategic addition to its leadership team as the company strengthens its engagement with India’s evolving healthcare and life sciences ecosystem.

Mittal joins AstraZeneca after an illustrious tenure at the Federation of Indian Chambers of Commerce and Industry (FICCI), where he played a pivotal role in shaping policy dialogue across healthcare, pharmaceuticals, medical technology, biotechnology, and public health. His appointment reflects AstraZeneca’s continued focus on strengthening stakeholder engagement, policy advocacy, and collaborative partnerships that support innovation-driven healthcare delivery in India.

With close to 30 years of professional experience, Mittal has established himself as one of the country’s most respected voices in healthcare policy and industry engagement. During his association with FICCI, he worked extensively with the Government of India, regulatory bodies, healthcare providers, multinational corporations, and industry associations, facilitating discussions on healthcare reforms, pharmaceutical regulations, medical technology adoption, digital health, and access to innovative therapies.

His deep understanding of the healthcare policy landscape is expected to further enhance AstraZeneca’s efforts to build meaningful collaborations with policymakers, industry stakeholders, academia, and patient advocacy groups. The appointment also aligns with the company’s broader strategy of advancing science-led innovation while contributing to the development of a resilient and future-ready healthcare ecosystem.

AstraZeneca has consistently strengthened its presence in India through investments in research, innovation, and access to advanced therapies across oncology, cardiovascular, renal and metabolic diseases, respiratory diseases, rare diseases, and vaccines. As India’s healthcare sector continues to evolve with increasing emphasis on innovation, value-based care, and public-private partnerships, corporate affairs leadership has become integral to driving sustainable business growth and shaping healthcare policy conversations.

Industry observers believe Mittal’s extensive experience in government relations and strategic stakeholder engagement will play a significant role in supporting AstraZeneca’s long-term vision of expanding patient access to innovative medicines while contributing to policy frameworks that foster healthcare innovation and equitable care delivery.

His appointment also underscores the growing convergence between industry, government, and healthcare institutions in addressing complex healthcare challenges. With rising investments in pharmaceutical innovation, digital health, and healthcare infrastructure, experienced policy leaders are expected to play a critical role in enabling collaboration that benefits patients and the broader healthcare ecosystem.

As AstraZeneca Pharma India continues to reinforce its commitment to scientific excellence and patient-centric innovation, the induction of Praveen K. Mittal into its leadership team represents a strategic step toward strengthening institutional partnerships and advancing the company’s mission of transforming healthcare through innovation, collaboration, and sustainable growth.